Evidence map›Paper›PMID 36090575›Full record

ArticleFrontiers in pediatrics2022

Case report: Novel compound heterozygous missense mutations in the

Xin Xu, Fen Lu, Senjie Du, Xiaoke Zhao, Hongying Li, Li Zhang, Jian Tang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xin XuDepartment of Rehabilitation, Children's Hospital of Nanjing Medical University, Nanjing, China.
Fen LuDepartment of Rehabilitation, Children's Hospital of Nanjing Medical University, Nanjing, China.
Senjie DuDepartment of Rehabilitation, Children's Hospital of Nanjing Medical University, Nanjing, China.
Xiaoke ZhaoDepartment of Rehabilitation, Children's Hospital of Nanjing Medical University, Nanjing, China.
Hongying LiDepartment of Rehabilitation, Children's Hospital of Nanjing Medical University, Nanjing, China.
Li ZhangDepartment of Rehabilitation, Children's Hospital of Nanjing Medical University, Nanjing, China.
Jian TangDepartment of Rehabilitation, Children's Hospital of Nanjing Medical University, Nanjing, China.
Second Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Spastic paraplegia type 54 (SPG54) is a rare inherited autosomal recessive disorder, and a complex hereditary spastic paraplegia (HSP) caused by mutations in the phospholipase Case presentation: We report a 9 years and 5 months old Chinese girl with progressive spasm of the lower limbs, muscle weakness and intellectual disability. Brain magnetic resonance imaging (MRI) showed periventricular leukomalacia and thinning of the corpus callosum. According to the Wechsler Intelligence Scale, her IQ is 42. By whole exome sequencing, novel compound heterozygous missense mutations in the Conclusions: Our study reports a very rare case of complicated HSP caused by two novel compound heterozygous mutations in the

Indexed as

childrencompound heterozygous mutationsDDHD2intellectual disabilityspastic paraplegia

Identifiers

PMID36090575
PMCPMC9458848
OpenAlexW4293224887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.